000 | 01557 a2200421 4500 | ||
---|---|---|---|
005 | 20250515175509.0 | ||
264 | 0 | _c20090813 | |
008 | 200908s 0 0 eng d | ||
022 | _a1524-4563 | ||
024 | 7 |
_a10.1161/HYPERTENSIONAHA.109.129171 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEllison, David H | |
245 | 0 | 0 |
_aThiazide effects and adverse effects: insights from molecular genetics. _h[electronic resource] |
260 |
_bHypertension (Dallas, Tex. : 1979) _cAug 2009 |
||
300 |
_a196-202 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlood Pressure Determination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperglycemia _xchemically induced |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aHypokalemia _xchemically induced |
650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMolecular Biology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aThiazides _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLoffing, Johannes | |
773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 54 _gno. 2 _gp. 196-202 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/HYPERTENSIONAHA.109.129171 _zAvailable from publisher's website |
999 |
_c18981480 _d18981480 |